Yu Life Limited announced that it will receive its series C round of equity funding on July 7, 2022.

On the same date, the company received its first tranche. The company has received £100,000,000 in the tranche. The transaction was led by new investor Dai-ichi Life Holdings, Inc. and also involved participation from returning investors Creandum AB, Phoenix Court Group, Target Germanium GmbH, Latitude Ventures, Anthemis Exponential Ventures, OurCrowd Ltd., Notion Capital Managers LLP, MMC Ventures Limited, Eurazeo SE. The company raised funding at the post-money valuation of £672,008,000. The company has raised £173,042,060 in funding till date.